Status: current, Defined. Date: 31-Oct 2010. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3024221000168117 | B-Dose (Biological Therapies) (cyanocobalamin 1 mg / 2 mL + dexpanthenol 5 mg / 2 mL + nicotinamide 50 mg / 2 mL + pyridoxine hydrochloride 10 mg / 2 mL + riboflavin sodium phosphate 5 mg / 2 mL + thiamine hydrochloride 20 mg / 2 mL) injection, 3 x 2 mL vials (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
3024231000168119 | B-Dose (Biological Therapies) injection, 3 x 2 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
B-Dose (Biological Therapies) injection, 3 x 2 mL vials | Is a | trade product pack | true | Inferred relationship | Some | ||
B-Dose (Biological Therapies) injection, 3 x 2 mL vials | Is a | thiamine hydrochloride 20 mg/2 mL + riboflavin sodium phosphate 5 mg/2 mL + nicotinamide 50 mg/2 mL + dexpanthenol 5 mg/2 mL + pyridoxine hydrochloride 10 mg/2 mL + cyanocobalamin 1 mg/2 mL injection, 3 x 2 mL vials | true | Inferred relationship | Some | ||
B-Dose (Biological Therapies) injection, 3 x 2 mL vials | has TPUU | B-Dose (Biological Therapies) injection, 2 mL vial | true | Inferred relationship | Some | 1 | |
B-Dose (Biological Therapies) injection, 3 x 2 mL vials | has TP | B-Dose (Biological Therapies) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
B-Dose (Biological Therapies) injection, 3 x 2 mL vials | Is a | True | B-Dose (Biological Therapies) injection, 3 x 2 mL vials | Inferred relationship | Some |
Reference Sets
Trade product pack reference set